Kura Insider Filing: SVP Doyle Vesting Event and Sell-to-Cover Disposition
Rhea-AI Filing Summary
Kura Oncology SVP, Finance & Accounting Thomas Doyle acquired 24,966 shares of Kura common stock on 09/27/2025 at a reported price of $0, increasing his direct holdings to 114,370 shares. On 09/29/2025 he sold 4,541 shares at $8.9422 per share as a sell-to-cover transaction to satisfy taxes tied to the vesting of 1/6th of performance-based restricted stock units (PSUs). The filing notes that one performance milestone was achieved on 09/27/2025, triggering the vesting event for that tranche; the Reporting Person also reports 500 shares indirectly held in a spouse's 401(k). After the transactions the Reporting Person beneficially owns 109,829 shares.
Positive
- 24,966 shares vested on 09/27/2025, reflecting achievement of a PSU performance milestone
- Significant retained ownership after transactions: 109,829 shares beneficially owned
Negative
- 4,541 shares sold on 09/29/2025 at $8.9422 per share (sell-to-cover for taxes)
Insights
TL;DR: Insider received PSUs that vested and sold a small tranche to cover taxes, leaving substantial ownership.
The 24,966-share acquisition at a reported price of $0 represents settlement/vesting of equity awards rather than an open-market purchase; the concurrent sell-to-cover of 4,541 shares at $8.9422 is a routine tax-related disposition. Net ownership remained large at 109,829 shares, indicating continued equity alignment with shareholders. This disclosure does not provide company-level financial metrics, valuation context, or signal a change in executive control. The activity is material only to the extent it reveals milestone achievement under PSU grants.
TL;DR: Governance action: performance milestone met triggering vesting; standard sell-to-cover executed for tax withholding.
The filing documents a governance-triggered compensation event: one specified development milestone was met on 09/27/2025, causing vesting of 1/6th of PSUs granted 05/31/2023. Such milestone-based vesting is a common performance alignment mechanism. The signature and timely Form 4 filing comply with Section 16 reporting. No departures, option exercises for cash, or transfers to affiliates are disclosed. The indirect holding of 500 shares in a spouse's 401(k) is properly reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,541 | $8.9422 | $41K |
| Grant/Award | Common Stock | 24,966 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.
